Nasdaq, Inc. has announced a significant leadership change within its financial team. On November 18, 2026, the company revealed that Michelle L. Daly will resign from her position as Senior Vice President, Controller, and Principal Accounting Officer, effective January 1, 2027. Daly will transition to a new role as Business Unit Chief Financial Officer and Head of Strategy & Revenue Operations for the Capital Access Platforms Division.
The appointment of Laura DeLorenzo as the new Senior Vice President, Chief Controller, and Principal Accounting Officer has also been confirmed, effective the same date. DeLorenzo has been with Nasdaq since 2016 and has held various roles, most recently serving as Vice President, Head of Global Reporting and Accounting Policy.
This leadership transition is crucial for Nasdaq as it navigates the complexities of the financial markets and aims to enhance its operational effectiveness. The changes reflect a strategic move to align its financial leadership with the company's growth objectives.
Background
Nasdaq, Inc. operates in the Security & Commodity Brokers, Dealers, Exchanges & Services sector, with the ticker symbol NDAQ listed on the Nasdaq exchange. The company is a large accelerated filer and has been actively involved in various recent filings, including its latest 8-K on November 18, 2026, which reported this leadership change.
What the Filing Says
The filing states, "On November 18, 2026, Nasdaq, Inc. announced that Michelle L. Daly has resigned as the Company’s Senior Vice President, Controller and Principal Accounting Officer, effective as of January 1, 2027." It further mentions, "On November 18, 2026, the Company announced the appointment of Laura DeLorenzo as Senior Vice President, Chief Controller and Principal Accounting Officer, effective as of January 1, 2027." This highlights the seamless transition intended by the company.
Impact
This change may affect Nasdaq's financial reporting and operational strategies, particularly within its Capital Access Platforms Division. The leadership shift could influence investor confidence and the company's approach to financial governance in a competitive market.
What's Next
The filing indicates that an amendment will be submitted within four business days after Ms. DeLorenzo’s compensation for her new role is determined. Further details regarding her compensation and any additional strategic initiatives related to this leadership change are expected to be disclosed in subsequent filings.
Read Next
Alterity Therapeutics appoints new auditor after PwC resignation
OZ Vision Inc. issues amended report on financial statements
TDH Holdings Reports First Half 2026 Financial Results
IES Holdings announces Q4 results, executive bonuses
Accustem Sciences Reports Q3 Results for 2026
IES Holdings Reports Annual Results, Highlights Growth Strategy






